← Back to news
NewsJOURNAL OF CLINICAL LIPIDOLOGYSunday, April 19, 2026 · 6 days ago

LDL-C target achievement after adding evinacumab in 2 patients with autosomal recessive hypercholesterolemia.

WHY IT MATTERS

Recent peer-reviewed research on Homozygous familial hypercholesterolemia that may be relevant for patients and caregivers.

Autosomal recessive hypercholesterolemia (ARH) is a rare form of genetic hypercholesterolemia consequent to pathogenic variants in the low-density lipoprotein receptor adaptor protein 1 (LDLRAP1) gene, coding for a protein responsible for moving low-density lipoprotein-receptor (LDL-R) to its s...

Read on PubMed
Read the original at Journal of clinical lipidology
ResearchPubMedHomozygous familial hypercholesterolemiaHumansCholesterol, LDL

Related conditions

Homozygous familial hypercholesterolemia

Related news

Int J Circumpolar Health · -250 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -220 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -220 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
Mol Ther Nucleic Acids · -52 days ago
The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena
Published in Mol Ther Nucleic Acids. Giangrande PH et al.